<DOC>
	<DOCNO>NCT01961947</DOCNO>
	<brief_summary>The purpose study compare immunogenicity safety ASP7374 ( cell-culture derive influenza vaccine ) approve egg-derived trivalent inactivate vaccine ( TIV ) adult ≥20 &lt; 65 year .</brief_summary>
	<brief_title>Study ASP7374 , Cell-culture-derived Influenza Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy medically stable , judged basis history concurrent disease . Subject understands procedure protocol willing comply protocol . Written inform consent obtain . Scheduled receive another vaccine study . Received influenza HA vaccine within 180 day prior screen . Received scheduled receive live vaccine within 28 day prior vaccination study vaccine , receive schedule receive inactivate vaccine toxoid within 7 day prior vaccination study vaccine . Diagnosis immune deficit past , family member ( within third degree kinship ) diagnosis congenital immunodeficiency syndrome . Received one follow medication treatment prior vaccination study vaccine . Received one follow medication treatment prior vaccination study vaccine : Interferon formulation , Drugs affect immune system , corticosteroid , GCSF , MCSF , Human immunoglobulin product , Blood product , Blood transfusion History anaphylactic shock allergic reaction generalize eruption due food ( include chicken , poultry , foodstuff derive chicken , et al . ) drug ( include vaccine ) allergy , fever ≥39.0°C within 2 day previous vaccination ( influenza vaccine others ) History seizure , except febrile seizure childhood</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>ASP7374</keyword>
	<keyword>Approved egg-derived vaccine</keyword>
	<keyword>Prevention seasonal influenza</keyword>
</DOC>